Grover disease shows Type 2 immune activation and improves with dupilumab
Br J Dermatol
.
2025 Jan 7:ljaf005.
doi: 10.1093/bjd/ljaf005.
Online ahead of print.
Authors
Michael J Murphy
1
,
Muhammad H Junejo
1
,
Okeroghene Rufin
1
2
,
Jeffrey M Cohen
1
,
Caroline A Nelson
1
,
William Damsky
1
3
Affiliations
1
Department of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA.
2
Frank H Netter School of Medicine, Quinnipiac University, North Haven, Connecticut, USA.
3
Department of Pathology, Yale School of Medicine, New Haven, Connecticut, USA.
PMID:
39775460
DOI:
10.1093/bjd/ljaf005
No abstract available